
Udeesha Tomar
AVP - Strategy and Solutions
Leading procurement research solutions across chemicals, materials, and food & beverages, with expertise in price forecasting and market analytics.
| Product | Region | Incoterm Basis | Price | Last Updated Month |
|---|---|---|---|---|
| Azithromycin | India | FOB | USD 127.09/KG | August 2026 |
| Azithromycin | China | CIF | USD 127.93/KG | August 2026 |
| Azithromycin | USA | CIF | USD 127.24/KG | August 2026 |
| Azithromycin | Germany | CIF | USD 127.35/KG | August 2026 |
| Azithromycin | Canada | CIF | USD 127.35/KG | August 2026 |
| Azithromycin | India | FOB | USD 135.54/KG | July 2026 |
| Azithromycin | China | CIF | USD 136.09/KG | July 2026 |
| Azithromycin | USA | CIF | USD 136.59/KG | July 2026 |
| Azithromycin | Germany | CIF | USD 136.94/KG | July 2026 |
| Azithromycin | Canada | CIF | USD 137.93/KG | July 2026 |
Stay updated with the latest Azithromycin prices, historical data, and tailored regional analysis
Asia
In India, the average price of Azithromycin was ~USD 137/KG in June. The market faced higher production and logistics costs during March-May as the Strait of Hormuz disruption affected petrochemical-linked pharmaceutical inputs and freight routes. India’s dependence on imported crude and chemical inputs increased exposure to the disruption, while air-freight costs also rose. However, regulated pricing for scheduled formulations restricted the extent to which manufacturers could pass higher costs into domestic selling prices. In China, Azithromycin averaged ~USD 138/KG in June. Chinese suppliers remained important in the upstream pharmaceutical-ingredient chain, while supply-chain concentration around antibiotic intermediates kept availability sensitive to production and trade conditions. Cost pressure eased toward June as shipping conditions began to improve.
Europe
In Germany, Azithromycin averaged ~USD 138/KG in June. European availability remained comparatively stable during H1’26, with no major critical antibiotic shortage signals reported during the period. However, higher freight, energy, and chemical-input costs increased the cost base for imported and locally supplied medicines. European policymakers also advanced measures to diversify critical-medicine supply chains and strengthen regional manufacturing capacity, reflecting concerns over dependence on concentrated overseas sources. These measures supported supply resilience but could increase procurement costs over time as buyers place greater emphasis on security of supply.
North America
In the USA, Azithromycin averaged ~USD 138/KG in June, while Canada recorded an average price of ~USD 140/KG. North American markets remained exposed to imported generic-drug supply, particularly from India and other Asian manufacturing hubs. Higher input and freight costs increased supply-side pressure, but strong generic competition and tender-based procurement constrained price pass-through. The exclusion of generic medicines from the initial pharmaceutical tariff measures also limited additional direct tariff pressure during H1’26. Consequently, higher costs were more likely to affect manufacturer margins and supply decisions than produce substantial increases in end-market prices.
Analyst Insight
According to Procurement Resource, Azithromycin prices are likely to remain sensitive to pharmaceutical input costs, freight conditions, and API availability, while competitive generic-drug procurement may limit significant price increases.
Related Report
Need Latest Azithromycin Prices?
Get real-time price assessments, periodic trends, forecasts and price driver insights across key global markets.
Our Clients

Turn price intelligence into action with the Procurement Resource Database. Log in or subscribe to unlock live price trends, historical charts, supplier databases, cost curves, and analyst-backed insights across chemicals, agriculture, energy, packaging, and more. Use these tools to benchmark your contracts, plan budgets with confidence, and stay ahead of market moves on every product you buy.
0
+Products
0
+Regions
0
+Subscriptions
Asia
Azithromycin prices in Asia remained closely linked to API availability and the concentration of upstream pharmaceutical manufacturing in China. India continued to rely significantly on imported APIs and intermediates, with government data showing China accounted for a major share of India’s overall API, bulk-drug, and intermediate imports in FY2024-25. The dependence was particularly relevant for antibiotics, making procurement costs sensitive to Chinese supply conditions.
India’s domestic pricing structure also limited the extent to which higher manufacturing costs could be passed through to finished formulations. The National Pharmaceutical Pricing Authority maintained ceiling prices for scheduled azithromycin formulations, while a 2025 review resulted in a revised ceiling calculation for the 250 mg tablet. This kept domestic formulation pricing more controlled even as API and manufacturing costs varied.
Europe
European azithromycin pricing remained shaped by regulated pharmaceutical procurement, supply security, and antimicrobial-stewardship measures. In May 2025, the European Medicines Agency recommended changes to several azithromycin indications to optimise its use and reduce antimicrobial-resistance risks. As a WHO-listed essential medicine, azithromycin continued to have an established role in treating bacterial infections, although its classification in the Watch category encouraged more selective use.
Supply conditions also remained important because antibiotic manufacturing was concentrated among a limited number of producing countries. This concentration increased the importance of reliable imports and inventory management for European buyers. Consequently, procurement decisions remained focused on balancing availability, regulatory requirements, and cost control rather than purely responding to spot-market movements.
North America
In North America, azithromycin prices were influenced by generic-drug procurement structures and product availability. During 2025, the US market also experienced supply pressure for certain azithromycin presentations. The American Society of Health-System Pharmacists reported discontinuations of several azithromycin oral-suspension packet products, including Pfizer’s products, leaving no available presentation in that specific shortage category at the time of its November update. Demand remained supported by continued use of azithromycin in appropriate bacterial infections, while antimicrobial-resistance concerns encouraged more targeted prescribing. WHO reported in 2025 that resistance to antibiotics was increasing across a substantial share of monitored pathogen-antibiotic combinations, reinforcing the shift toward more controlled antibiotic use.
A member of the macrolide class of antibiotics, azithromycin has a broad spectrum of activity. It is frequently used to treat a number of bacterial infections, including skin infections, sexually transmitted diseases, and infections of the respiratory tract. By blocking the creation of bacterial proteins, azithromycin stops the growth and spread of bacteria.
Its lengthy half-life, which enables once-daily dosing and provides patients with convenience, is one of its important characteristics. Additionally, it has significant tissue penetration, making it possible to treat infections in different bodily regions effectively. Its favorable side effects and suitability for those with penicillin allergies make azithromycin a desirable and frequently given antibiotic.
C38H72N2O12
Veterinary medicine, Disease prevention in agricultural crops
Pfizer, Akron, Teva, Mylan, Zydus Pharmaceuticals, Sandoz, Aurbindo Pharma, CSPC Ouyi Pharmaceutical, Hainan Poly Pharm
CurrencyUS$ (Data can also be provided in local currency)
Supplier Database AvailabilityYes
Customization ScopeThe report can be customized as per the requirements of the customer
Post-Sale Analyst Support360-degree analyst support after report delivery
Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.
The production of intermediate molecules is the first step in the synthesis of azithromycin. Amination, acylation, esterification, cyclization, purification, isolation, and quality control are the next steps. The intermediate component is processed to attach molecules with amine and acyl functional groups, which are then subjected to cyclization to combine all the compounds into one finished product, in this case azithromycin.
In a very certain temperature and environment, the process is watched over and managed. Following cyclization, the chemical compound is refined and isolated to guarantee complete purity and retain the chemical compound's quality.
Our Price Analysis Methodology

AVP - Strategy and Solutions
Leading procurement research solutions across chemicals, materials, and food & beverages, with expertise in price forecasting and market analytics.

Experience how Procurement Resource transforms raw material price data into clear, decision ready intelligence. Optimise your performance with reliable, expert market data and analysis. Schedule your demo today to experience a live walk-through where our experts will showcase interactive price charts, forecasted prices, and insights driving the prices for your key commodities, tailored to your workflows. Contact us now!
Our Team will be happy to assist you
We are just a text away
Still Need Help?
Unlock full access to Procurement Resource's price databases, interactive charts, and short-term forecasts for thousands of commodities. Elevate your sourcing decisions by comparing prices across regions, downloading historical data, and layering in analyst-backed insights, all with our flexible plans that scale as your portfolio grows.
Still have any Questions
Contact Us



Price Trend Dashboard - What's Included
Price trends across a diverse portfolio of categories and products, spanning board to niche chemicals
Coverage extendable to grade-specific chemicals based on procurement requirements
Regular price tracking supported by robust historical datasets
News, policy updates, and key market drivers impacting price movements
Short-term and long-term price outlooks and forecasts
Supply–demand dynamics and capacity-driven market analysis